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Abstract
Purpose: To discharge a patient from the intensive care unit (ICU) is a complex decision-making
process because in-hospital mortality after critical illness may be as high as up to 27%. Static C-reactive
protein (CRP) values have been previously evaluated as a predictor of post-ICU mortality with
conflicting results. Therefore, we evaluated the CRP ratio in the last 24 hours before ICU discharge as a
predictor of in-hospital outcomes.
Methods: A retrospective cohort study was performed in 409 patients from a 6-bed ICU of a university
hospital. Data were prospectively collected during a 4-year period. Only patients discharged alive from
the ICU with at least 72 hours of ICU length of stay were evaluated.
Results: In-hospital mortality was 18.3% (75/409). Patients with reduction less than 25% in CRP
concentrations at 24 hours as compared with 48 hours before ICU discharge had a worse prognosis,
with increased mortality (23% vs 11%, P = .002) and post-ICU length of stay (26 [7-43] vs 11 [5-27]
days, P = .036). Moreover, among hospital survivors (n = 334), patients with CRP reduction less than
25% were discharged later (hazard ratio, 0.750; 95% confidence interval, 0.602-0.935; P = .011).
Conclusions: In this large cohort of critically ill patients, failure to reduce CRP values more than 25% in
the last 24 hours of ICU stay is a strong predictor of worse in-hospital outcomes.
© 2012 Elsevier Inc. All rights reserved.
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1. Introduction
In-hospital mortality after intensive care unit (ICU)
discharge has been reported to be as high as up to 27%
[1,2]. Deaths occurring in the post-ICU period could be
related to a premature discharge (in a patient with unresolved
critical condition) or to a new process that occurred after ICU
stay and that is not directly related to this period. An
adequate evaluation of the patient before ICU discharge
could probably detect individuals at high risk of unfavorable
outcomes, therefore reducing readmissions to ICU and in-
hospital mortality [3,4].
Discharging the patient from the ICU is a complex
decision-making process. The 1999 American College of
Critical Care Medicine Guidelines for Admission, Discharge
and Triage of ICU patients [5] suggests that one should be
discharged from the ICU when his “physiologic status has
stabilized and the need for ICU monitoring and care is no
longer necessary” but gives no information on objective
parameters or markers that should be used to evaluate
these individuals.
C-reactive protein (CRP) is an acute–phase protein that
has been extensively evaluated in the ICU population [6].
Its concentrations correlate with ongoing organ dysfunction
and ICU mortality [7] and have recently been evaluated as
a predictor of mortality and readmission to ICU, with
conflicting results [8-11]. All of the previous studies,
however, evaluated static CRP values at discharge, and
none reported the trend in CRP concentrations in
this period.
Dynamic analysis of biologic variables seems more
relevant than isolated values to predict outcomes in critical
care illness [12-14]. Evaluation of CRP trend pattern in the
first days of ICU admission has been reported as useful in
discriminating outcomes in community-acquired pneumonia
[15] and septic patients [16] and useful to help in the clinical
decision-making process regarding ICU-acquired infections
[17-19].
Therefore, we hypothesized that a reduction in the CRP
values in the last 24 hours before ICU discharge would be
useful to predict in-hospital outcomes.
2. Methods
2.1. Study subjects
This is a single-center retrospective cohort study consist-
ing of 1043 consecutive critically ill patients admitted to the
medical ICU of the emergency department of the Hospital
das Clínicas of São Paulo in Brazil. Data were retrieved from
January 2005 to December 2008, and all data were collected
prospectively. However, hypotheses were generated before
data analysis and after data collection. The present study was
approved by the local research ethics committee (CAPPesq).
Because of its strictly observational design, informed
consent was waived.
We selected only patients who were discharged alive from
the ICU and with at least 72 hours of length of stay (LOS).
For patients with multiple ICU admissions, only the first
admission was recorded. Exclusion criteria were patients
with any missing data (Fig. 1) or patients transferred to
other ICUs.
2.2. Data collection
Data were extracted from our electronic database,
including demographics (age and sex), comorbidities
(systemic arterial hypertension, diabetes mellitus, chronic
renal failure, chronic obstructive pulmonary disease, chronic
liver disease, chronic heart failure, acquired immunodefi-
ciency syndrome, and cancer diagnosis), syndrome at
admission, source of admission, type of admission, severity
of illness (Acute Physiology and Chronic Health Evaluation
II [APACHE II] [20] and Sequential Organ Failure
Assessment [SOFA] [21]), use of noninvasive positive
pressure ventilation, mechanical ventilation, renal replace-
ment therapy, or vasoactive drugs. We also recorded the hour
of discharge from the ICU, the LOS in the hospital before ICU
admission, and the LOS during the ICU period. The follow-up
of patients was extended to in-hospital death/survival, and
the post-ICU hospital LOS was recorded. Any unsched-
uled ICU readmission in the same hospitalization after
discharge from our unit was recorded. We were unable to
1043 patients
admitted to the ICU
304 patients died in ICU
189 patients discharged 
before 72h of ICU stay
550 patients discharged 
after 72h of ICU stay
141 (26%) patients excluded:
- 128 with CRP measurements 
outside the  48/24 hours from the 
official hour of ICU discharge
- 06 with missing data
- 07 were transferred to other ICU
409 patients discharged from 
ICU after 72h of ICU stay and 
all variables were available
Fig. 1 Flow chart.
525.e10 O.T. Ranzani et al.
identify patients in our cohort who were discharged from
the ICU with orders of no resuscitation or limitation of
therapeutic efforts.
2.3. Laboratorial data
Blood samples were collected at 11 PM, according to
our ICU standard of care, including daily CRP measure-
ments and blood gas analysis. All samples were analyzed
in the central laboratory of the institution. We collected the
following laboratorial data at ICU discharge: arterial blood
gas analysis, lactate, albumin, hemoglobin level, white
blood cell and platelet counts, and CRP. C-reactive protein
measurement was performed with an immunoturbidimetric
method using a commercially available test (BIOTÉC-
NICA Indústria e Comércio Ltda, Minas Gerais, Brazil),
with reference range less than 5 mg/L. We retrieved the
following CRP values: at ICU admission, maximum value
during ICU stay, and in the last 48 and 24 hours before
ICU discharge. C-reactive protein ratio was calculated by
dividing the CRP concentration at 24 hours before ICU
discharge (CRP-24 h) to the CRP concentration at ICU
admission, maximum value, and at 48 hours before the
ICU discharge (CRP-48 h). To show the CRP trend as a
percentage value, CRP variation was calculated by
subtracting the CRP-24 h to CRP-48 h and dividing the
result to CRP-48 h. C-reactive protein values were only
included in the analysis if the result was inside a
Table 1 Clinical features
Whole group (n = 409) Survivors (n = 334) Nonsurvivors (n = 75) P a
Characteristics
Age, y (mean ± SD) 48.6 ± 19.4 46 ± 18.5 60.5 ± 19 b.001
Male sex, n (%) 210 (51) 174 (52) 36 (48) .521
APACHE II score, median (IQR) 16 (10-21) 15 (10-20) 20 (14-27) b.001
SOFA at admission, median (IQR) 5 (3-7) 4 (2-7) 6 (4-8) b.001
SOFA at discharge, median (IQR) 2 (1-3) 2 (1-3) 3 (1-5) b.001
Type of admission, n (%) .591
Medical 318 (78) 258 (77) 60 (19) .604
Scheduled surgery 13 (03) 12 (04) 01 (01) .313
Urgent surgery 78 (19) 64 (19) 14 (19) .921
Origin of patients, n (%) .001
Ward 134 (33) 95 (28) 39 (52) b.001
Emergency department 238 (58) 208 (62) 30 (30) b.001
Other ICU 15 (04) 13 (04) 02 (03) .610
Step-down unit 04 (01) 02 (01) 02 (03) .100
Operating room 13 (03) 11 (03) 02 (03) .563
Other hospital 05 (01) 05 (02) – .361
Comorbid conditions, n (%) 1 (0-2) 1 (0-2) 2 (1-3) b.001
Systemic arterial hypertension 188 (46) 140 (42) 48 (64) .001
Diabetes mellitus 86 (21) 65 (20) 21 (28) .101
Chronic renal failure 60 (15) 45 (14) 15 (20) .149
Chronic heart failure 53 (13) 35 (11) 18 (24) .002
Chronic coronary disease 43 (11) 28 (08) 15 (20) .003
Chronic obstructive pulmonary disease 32 (08) 18 (05) 14 (19) b.001
Chronic liver disease 14 (03) 12 (04) 2 (3) .510
AIDS 13 (03) 13 (04) - .138
Cancer 49 (12) 35 (11) 14 (19) .048
Syndrome at admission, n (%) .134
Respiratory failure 117 (29) 98 (29) 19 (25) .942
Shock b 66 (16) 46 (14) 20 (27) .006
Sepsis/severe sepsis 53 (13) 40 (12) 13 (17) .212
CNS disorders 51 (13) 43 (13) 08 (11) .601
Renal failure 16 (04) 14 (04) 02 (03) .368
Electrolytes disturbances 16 (04) 15 (05) 01 (01) .202
Severe trauma 12 (03) 12 (04) – .096
Exogenous intoxication 09 (02) 08 (02) 01 (01) .486
Other 69 (16) 58 (17) 11 (15) .573
AIDS indicates acquired immunodeficiency syndrome; CNS, central nervous system.
a P values refer to a comparison between survivors vs nonsurvivors.
b There were 57 patients (86%) with septic shock, 5 (08%) with hypovolemic shock, and 4 (06%) with cardiogenic shock.
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predefined time window to avoid bias due to CRP half-life
and sample-collect routine. Regarding the CRP-48 h, only
results collected up to 50 hours (2 hours of difference)
were considered valid. The same time window was used
for the CRP-24 h. Intensive care unit discharge time was
collected from the hospital's official system. All the
laboratorial results were available to the intensivists before
the discharge decision.
2.4. Statistical analysis
Data are presented as the mean ± SD or median and
25th and 75th percentiles (interquartile range [IQR]) if they
are normal or skewed distributed, respectively. Baseline
characteristics of the post-ICU survivors and nonsurvivors
were compared using the Mann-Whitney U or unpaired
t test, as appropriate. The Fisher exact test or χ2 statistics
were used for dichotomous variables. Binary logistic reg-
ression was used to evaluate the prognostic factors to in-
hospital outcome. Variables with P b .20 on the univariate
analysis were included in the multivariate analysis and
selected using likelihood ratio backward elimination
method. The backward elimination method was performed
using P b .05 as statistical significant, and variables with
P b .10 were retained in the final multivariate model
after the likelihood ratio analysis. Single collinearity was
evaluated with the Pearson correlation among the inde-
pendent variable, and multicollinearity was evaluated with
the variance inflation factor [22]. The odds ratio (OR) and
corresponding 95% CI for each variable were computed.
The discriminative ability of the model to predict the
outcome of patients was assessed by the area under the
Table 2 Clinical features
Whole group (n = 409) Survivors (n = 334) Nonsurvivors (n = 75) P a
Support during ICU stay, n (%)
Noninvasive positive ventilation 75 (18) 60 (18) 15 (20) .681
Mechanical ventilation 214 (52) 167 (50) 47 (63) .047
Renal replacement therapy 75 (18) 53 (16) 22 (29) .006
Vasoactive drugs 152 (37) 110 (33) 42 (56) b.001
Hour of discharge, n (%) .719
Night (22:00-06:59) 60 (14.7) 48 (14.4) 12 (16)
Day (07:00-21:59) 349 (85.6) 286 (85.6) 63 (84)
Readmission, n (%)
Unplanned readmission 71 (17) 35 (11) 36 (48) b.001
LOS, d (IQR)
Preadmission 2 (0-6) 1 (0-6) 4 (1-11) b.001
ICU 7 (4-12) 6 (4-11) 9 (5-15) .002
Post-ICU 14 (7-31) 13 (6-28) 21 (7-39) .158
Hospital 29 (17-50) 26 (16-48) 38 (24-57) .001
Laboratorial data at ICU discharge, median (IQR)
pH 7.42 (7.39-7.45) 7.42 (7.39-7.45) 7.42 (7.39-7.45) NS
pCO2 (mm Hg) 36.4 (32.1-40.9) 36.4 (32.6-40.4) 36.3 (31.8-43.2) NS
SBE (mEq/L) −0.5 (−2.6 to 1.9) −0.5 (−2.8 to 1.6) 0.5 (−3.0 to 3.7) .146
Lactate (mmol/L) 1.8 (11.3-2.3) 1.8 (1.3-2.3) 1.9 (1.2-2.6) .127
Hemoglobin level (g/dL) 9.1 (7.9-11.0) 9.5 (8.1-11.2) 8.6 (7.6-9.6) b.001
White blood cell count (per L) 10.0 (6.7-13.5) × 109 9.9 (6.6-13.3) × 109 10.4 (7.0-13.7) × 109 NS
Platelets (per L) 249.0 (166.0-365.0) × 109 254.0 (169.7-370.5) × 109 214.0 (149.0-338.0) × 109 .117
Creatinine (μmol/L) 70.7 (53.0-114.9) 69.8 (53.0-106.1) 87.5 (61.9-152.1) .004
Albumin (g/L) 27 (23-31) 27 (23-32) 24 (21-28) b.001
CRP at admission (mg/L) 102.0 (33.5-180.5) 98.3 (33.1-176.3) 108.0 (37.6-200.0) .128
CRP maximum (mg/L) 162.0 (95.4-236.5) 160.0 (93.2-226.8) 170.0 (102.0-268.0) .109
CRP-48 h (mg/L) 65.2 (31.8-130.0) 64.8 (31.4-128) 72.4 (33.3-142) .184
CRP-24 h (mg/L) 48.9 (26.7-112.0) 47.0 (25.3-107.8) 75.9 (36.4-136) .022
CRP-24 h/CRP at admission 0.65 (0.28-1.28) 0.65 (0.26-1.27) 0.66 (0.40-1.40) .419
CRP-24 h/CRP maximum 0.43 (0.22-0.72) 0.40 (0.21-0.72) 0.49 (0.28-0.69) .350
CRP-24 h/CRP-48 h 0.84 (0.65-1.03) 0.80 (0.63-1.01) 0.91 (0.75-1.06) .012
CRP reduction N 25%, b n (%) .002
Yes 163 (40.0) 145 (43.4) 18 (24.0)
No 246 (60.0) 189 (56.6) 57 (76.0)
NS indicates not significant; SBE, standard base excess.
a P values refer to a comparison between survivors vs nonsurvivors.
b Patients who had a reduction more than 25% in CRP values between 48 and 24 hours before ICU discharge.
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receiver operating characteristic curve. Calibration ability
for the model was evaluated by Hosmer-Lemeshow
goodness-of-fit statistic. Receiver operating characteristic
curves were used to identify the optimal cutoff values for
outcome associations. The optimal cutoff was defined as the
value associated with the highest sum of sensitivity and
specificity − 1.
The effect of CRP variation on time to hospital discharge
after ICU discharge was assessed by cumulative hazard ratio
(HR) estimates and adjusted Cox proportional hazards
analysis [23], adjusting for age, SOFA at ICU discharge,
admission from ward, shock status at ICU admission,
comorbidities, and hemoglobin level concentrations at
ICU discharge.
Significance was considered as P b .05 (2 tailed). All
statistical tests were performed using the commercial
package SPSS 13.0 for Windows (SPSS Inc, Chicago, Ill).
3. Results
During the study period, a total of 550 patients fulfilled
the inclusion criteria. Of these, 128 patients (23%) had CRP
measurements outside the time range mentioned above,
6 had data missing, and 7 patients were transferred to another
ICU. Thus, 409 patients were included in the analysis
(Fig. 1). There were no differences among patients included
or not in the analysis regarding disease severity and
outcomes (APACHE II, P = .581; age, P = .114; ICU
LOS, P = .985; unplanned readmission, P = .088; and in-
hospital death, P = .490).
Overall in-hospital mortality was 18.3% (n = 75). Two
hundred ten patients were male (51%), and mean age was
48.6 years (±19.4 years). Most of the patients were admitted
from the emergency department (58%) or ward (33%)
because of a medical condition (78%). Median APACHE II
score was 16 (IQR, 10-21). The most common syndromes at
admission were respiratory failure (29%) and shock (16%).
Table 1 summarizes other demographic data. The 75 patients
who died after ICU discharge were older (60.5 ± 19 vs 46 ±
18.5, P b .001), had a more severe disease at ICU admission
(APACHE II score, 20 [IQR, 14-27] vs 15 [IQR, 10-20], P b
.001), were more likely to have a chronic disease before ICU
admission (2 [IQR, 1-3] vs 1 [IQR, 0-2], P b .001], were
more often admitted from the ward (52% vs 28%, P b .001),
and more likely to have a shock status at admission (27% vs
14%, P = .006). As expected, patients who required more
support during the ICU stay were more prone to have a poor
prognosis, as shown on Table 2.
Regarding CRP, in the univariate analysis, the values at
ICU admission, maximum, and CRP-48 h were not
significantly different between post-ICU survivors and
nonsurvivors. By contrast, higher CRP-24 h value was
associated with in-hospital death (75.9 [IQR, 36.4-136] vs
47 [IQR, 25.3-107.8] mg/L, P = .022). When adjusted by
CRP values at ICU admission and maximum, the CRP
ratio was similar between survivors and nonsurvivors.
However, the relative change of CRP between 48 and
24 hours before discharge was different between the
2 groups (0.80 [IQR, 0.63-1.01] vs 0.91 [IQR, 0.75-1.06],
P = .012), as shown on Table 2. Considering the area
Fig. 2 Time to hospital discharge. Time to discharge from the
hospital after ICU discharge. Assessed by cumulative hazard
estimates and Cox proportional hazards analysis, with adjusting for
age, SOFA at discharge, admission from ward, comorbidities,
shock status at ICU admission, and hemoglobin level at ICU
discharge (HR, 0.750; 95% CI, 0.602-0.935; P = .011).
Table 3 Bivariate and multivariate (independent) predictors of in-hospital mortality after ICU discharge
Variable Unadjusted OR (95% CI) P Adjusted OR (95% CI) P VIF
Age 1.043 (1.028-1.058) b.001 1.035 (1.016-1.054) b.001 1.399
SOFA at discharge 1.359 (1.202-1.538) b.001 1.220 (1.056-1.409) .007 1.117
Admission from ward 2.725 (1.634-4.546) b.001 2.745 (1.502-5.017) .001 1.065
Comorbidities 1.519 (1.272-1.814) b.001 1.292 (1.025-1.630) .030 1.393
Shock status at ICU admission 2.277 (1.251-4.144) .006 2.594 (1.257-5.355) .010 1.040
Hemoglobin level at ICU discharge 0.782 (0.683-0.895) b.001 0.776 (0.664-0.906) .001 1.080
CRP reduction b25% a 2.427 (1.370-4.310) .002 2.703 (1.387-5.291) .004 1.025
a Patients who had a reduction less than 25% in CRP values between 48 and 24 hours before ICU discharge. Hosmer-Lemeshow χ2, 5.000;
P = .758; C-statistic, 0.821 (0.769-0.872); P b .001.
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under the curve for different CRP variables, just the values
at discharge have significantly results. For CRP-24 h, the
discriminating ability to in-hospital death was 0.584
(0.514-0.654, P = .022), and for CRP-24 h/CRP-48 h, it
was 0.593 (0.523-0.662, P = .012). The best cutoff for the
CRP ratio was a decrease of 25% in CRP value when
comparing 24- from 48-hour values. Patients who had CRP
reduction less than 25% had a worse prognosis, with an
increased mortality (23% vs 11%, P = .002) and post-ICU
LOS (26 [IQR, 7-43] vs 11 [IQR, 5-27] days, P = .036).
More notably, even among hospital survivors (n = 334),
patients in the CRP-reduction-less-than-25% group were
discharged later from hospital (HR, 0.750; 95% CI, 0.602-
0.935; P = .011; Fig. 2).
Independent predictors of post-ICU mortality after a
backward stepwise multivariate logistic regression analysis
were age, SOFA score at ICU discharge, admission from
ward, chronic comorbidities, shock status at ICU admis-
sion, hemoglobin level at ICU discharge, and CRP
reduction less than 25%. Among these, hemoglobin level
at ICU discharge was a protective factor to in-hospital
mortality. This model has an excellent discrimination (C-
statistic, 0.821) and is well calibrated (Hosmer-Lemeshow
P = .758, Table 3).
Regarding unplanned ICU readmission, a secondary and
prognostic end point after ICU discharge, CRP-48 h and
CRP-24 h (static values) were not able to differentiate
readmitted from not-readmitted patients (P = .622 and P =
.710, respectively). By contrast, CRP reduction less than
25%, a dynamic variable, was a good tool to predict this
unfavorable outcome, both early and late (Table 4).
4. Discussion
Defining the appropriate time to discharge a patient from
the ICU is an important decision that has a direct impact on
in-hospital mortality. This study showed that, in a
retrospective cohort evaluation of 409 critically ill patients,
a decrement in CRP concentration lower than 25%
considering CRP concentrations 24 and 48 hours before
ICU discharge is associated with an increase in-hospital
mortality, unplanned ICU readmission, post-ICU LOS, and
later hospital discharge.
Several studies have evaluated the utility of CRP
measurements on the ICU [6,7,17]. In this study, we
found that, at ICU discharge, the predischarge CRP
concentrations were associated with in-hospital mortality
in a univariate analysis. However, in the multivariate
analysis, this finding did not persist. C-reactive protein and
other biologic variables are dynamic because their
concentrations depend on the intensity of the inflammatory
stimulus. The result of reduced in-hospital mortality with
CRP decrease more than 25% may be due to an improved
resolution of latent inflammation in these subjects.
Interestingly, the best value of CRP reduction in this
study was 25%, similar to the results of Yentis et al [16]
and Claeys et al [24] that evaluated the trend of CRP
during a septic shock event on the ICU. Coelho et al [15],
which evaluated 53 patients with community-acquired
pneumonia, also identified that a reduction in CRP
concentrations after 3 days of antibiotic treatment was a
marker of good clinical outcome. This conjunct of findings
emphasizes the opinion that the trend appears much more
important for the clinical evaluation of a biologic variable
during critical illness scenarios than the absolute values.
The lack of an association between the static values of
CRP at ICU discharge and the prediction of post-ICU
outcomes has been reported in other studies [10,11].
Comparing the present study with the previous ones, ours
was predominantly composed of medical patients, and our
cohort had more severe disease at admission and longer
ICU LOS. Conversely, in 2 large prospective cohorts that
have also evaluated the static CRP values, medical patients
with higher CRP values at discharge were more prone to
death at both short- [9] and long-term evaluations [8]. The
different measurement techniques across the studies could
partially account for these disparate findings. Because
every patient may have a self-pattern of response to
inflammatory stimulus, the use of CRP variation can
possibly decrease the bias of individual differences and the
influence of these confounders [25]. Another interesting
finding of the present study is that CRP reduction less than
25% was a good marker of risk of ICU readmission. Static
values of CRP have been described as markers for
readmission in surgical patients [26] and in a case-control
study [27,28], but as far as we are aware, predischarge
CRP variation was not used for this purpose. Intensive care
unit readmission is a major factor independently associated
with in-hospital mortality and also with burden costs and
increased hospital LOS [28]. Another intriguing finding is
that, among patients who were discharged alive, those with
CRP reduction less than 25% were discharged from
hospital later, corroborating this hypothesis.
Some of the strengths of this study shall be emphasized.
First, this is a large cohort of critically ill patients, and the
data were prospectively collected in a period of 4 years.
Second, we intentionally removed patients who remained in
the ICU for less than 72 hours from the analysis, thus
selecting a subgroup of more severely ill individuals. In
Table 4 Univariate analysis of CRP reduction less than 25%
as a predictor of unplanned readmission at ICU
Variable OR (95% CI) P
Unplanned readmission (n = 71) 2.415 (1.344-4.340) .003
After 7 d (n = 33) 3.226 (1.301-7.999) .008
After 14 d (n = 52) 1.944 (1.017-3.717) .042
After 21 d (n = 62) 2.113 (1.151-3.879) .014
Patients who had a reduction less than 25% in CRP values between 48
and 24 hours before ICU discharge.
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addition, the indexes described here are easy to interpret,
reasonably inexpensive, and may be readily implemented in
ICUs worldwide. However, despite these strengths, this
study has some shortcomings that must be acknowledged.
First, it is a retrospective and single-center analysis, thus
subjected to biases. Second, we were unable to identify the
cause of in-hospital death and the main reason for read-
mission after ICU discharge. Regarding readmission, it is
possible that some patients returned to the ICU for a reason
unrelated to the previous medical condition, including need
for observation in a monitored setting. On the other hand, it is
also possible that few discharged patients died in the wards
while waiting for an ICU bed. Both situations could have
interfered with our results. Third, we did not identify orders
of withdrawing and withholding at the ICU discharge,
although Azoulay et al [29] consider that these patients must
be included in the analysis of post-ICU mortality. Fourth,
potential confounders regarding CRP production and
patients who achieved a plateau with low CRP values earlier
than the moment of ICU discharge were not evaluated. For
clinical purposes, we advise that this new variable should be
evaluated in other critically ill patients and other centers.
In this large retrospective cohort of complex critically ill
patients (ICU LOS N72 hours), we identified a new useful
tool to help the physician in identifying patients at high risk
of death after ICU discharge in addition to classical risk
factors. Moreover, patients with a CRP reduction less than
25% had more than two and a half times the odds of dying in
hospital after ICU discharge when compared with patients
with a CRP reduction greater than 25%.
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